Cara Therapeutics Inc.
Rank 19
About
Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.
$9.8400
USD
-4.34%
Market cap
$456,750,168
Total volume
$4,098,842
Shares outstanding
46,417,700
Rank 19
About
Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
CARA |
$4,098,842
|
100% |
$9.8400
|
Chart